Adopting Oncology Biosimilars Into Clinical Practice: How Pharmacists Can Help Pave the Way
This activity will apply knowledge of the challenges associated with the adoption of biosimilars into clinical practice to a real-world patient and clinician counseling scenario.
Available Therapies for Atypical Hemolytic Uremic Syndrome: The Roles of Specialty and Infusion Pharmacists
This activity will express the incidence, etiology, and clinical presentation associated with atypical hemolytic uremic syndrome (aHUS).
The Expanding Therapy Landscape for Paroxysmal Nocturnal Hemoglobinuria: A Review for Specialty and Infusion Pharmacists
This activity will discuss the prevalence and pathophysiology of paroxysmal nocturnal hemoglobinuria.
Examining Hemophilia Treatments: Updates for Specialty Pharmacists
This activity will present the latest research for individualizing therapy using pharmacokinetic parameters, along with the extended half-life products on the market as well as emerging therapies.